Contact Supplier

Contact Supplier

To get in touch with Skyepharma Production S.A.S., simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier


    Development partner Skyepharma bringing innovation and modified release advances to BIO-Europe Spring, PBP World Meeting and euroPLX

    news-releasesSkyepharma Production S.A.S.
    March 9th 2022

    Saint-Quentin-Fallavier, France: – Skyepharma Productions S.A.S. (Skyepharma), the French-based  fully-formed contract development and manufacturing organisation (CDMO), will be attending three prominent events within the course of a single week in late March to early April 2022.

    Two of the events will be happening simultaneously from March 28 to March 31 inclusive; the online digital BIO Europe Spring 2022 networking and partnering event and the 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP) in the Netherlands port city of Rotterdam.

    The third event, euroPLX78 will be a two-day event opening April 4, 2022, at Portugal’s Hotel Cascais Miragem, near Lisbon

    Strong teams

    Skyepharma’s presence at BIOEurope will be headed by Pharmaceutical Development Director, Dr. Aline Moulin, who will be able to provide greater detail about the support Skyepharma can offer to solve complex formulation challenges with oral solid dosage forms. This maintains Skyepharma’s close relationship with the BIO series, having attended previous BIO-Europe events over the past five years.

    In Rotterdam, the Skyepharma team for PBP World meeting will be Development Project Manager Dr. Marion Quaillet, Development & Innovation Project Manager Dr. Vanessa Bourgeaux, and PhD researcher Léo Picart, who will present two scientific posters on ‘Lipidic nanoencapsulation for poorly soluble APIs’ and ‘Release kinetics of press-coated tablets’.

    Partner for Development

    Four days after the BIO Europe and PBP events close, Skyepharma will be in Lisbon for the latest euroPLX marketplace exchange meeting. Here, the company will be represented by Chief Commercial Officer Laurent Rigaudeau and senior Business Development Manager Vincent Pasquier.

    At all these events, Skyepharma will be looking to forge new ‘Partner for Development’ relationships with organisations looking for collaboration and support in R&D, formulation development and Life Cycle Management for solid dosage forms. These include application of advanced technologies for modified controlled drug release: Geomatrix®: multi-layer tablet sustained and controlled release, Geoclock® tab-in-tab delayed release, and Soctec®: enteric capsule extended release.

    About Skyepharma Production

    Skyepharma is an independent French pharmaceutical CDMO, 100% owned by its management team and Bpifrance. Skyepharma is an expert CDMO specialised in the formulation, development and manufacturing of complex oral solid forms (OSD), with a specific expertise and proprietary technologies on modified release products.

    Skyepharma is based in Saint-Quentin-Fallavier, France. The current factory, dedicated to its OSD activity, occupies 22,000m2, on a 60,000m2 piece of land. Skyepharma has decided to allocate a portion of the available land (more than 20,000m2) to establish its SkyeHub Bioproduction, an innovative model designed to offer clinical and commercial production capacities to biotech companies. This SkyeHub model includes the construction of dedicated buildings, with specifically designed surfaces and premises, together with transverse support services such as quality, maintenance, batch release, etc.

    About BIO Europe Spring 2022

    The biannual BIO-Europe events are premier partnering conferences dedicated to driving forward partnering in the life sciences sector. They attracts an international “who’s who” from biotech, pharma and finance for high caliber networking.

    BIO-Europe Spring is being delivered digitally as a four-day online event, opening March 28. This will use forums, webinars and video conferencing technology to allow the same networking and knowledge sharing benefits as the ‘live’ event, along with the sophisticated partneringONE® platform to enable networking and meetings between financiers, innovators and companies across the life science value chain, from large biotech to start-ups.

    BIO Europe Spring will feature more than 2,700 assets posted online and representations from more than 50 countries worldwide.

    BIO Europe DIGITAL is organised by the EBD Group in association with the Washington DC-based Biotechnology Innovation Organisation. Further information at:

    About PBP 2022

    The Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP) World Meeting has become a well-established pharma industry event, attracting scientists from all over the world. The event is biennial, with previous meetings held in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow , and Granada (2018), with a 2021 event held online because of the Covid-19 pandemic.

    The 13th World Meeting, PBP 2022, is held over four days, opening March 28  at the RACC Rotterdam Ahoy Convention Center in The Netherlands.

    The event is expected to attract around 1,000 delegates with hundreds of 1000 abstracts posted.

    The conference and the accompanying ResearchPharm® exhibition provide a cross-disciplinary platform for pharmaceutical scientists working in all fields of drug product development in industry, academia and regulation.

    PBP 2022 will have parallel sessions on industry-related topics presented by distinguished invited speakers along with two further parallel tracks for oral presentations on Pharmaceutics, Biopharmaceutics and Pharma Technology.

    More information at:

    About EuroPLX 78

    The 78th euroPLX Marketplace (euroPLX78) is an exchange for licenses, products, assets, distribution deals and other Pharma Business Opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices.

    These events, organised by management consultancy and online exchange, RauCon GmbH, provide a quarterly forum for networking and creating new pharma business opportunities.

    euroPLX78 will be a two-day event opening April 4, 2022, at Portugal’s Hotel Cascais Miragem, near Lisbon, featuring both face to face networking events and live video networking via RauCon’s advanced online partnering systems that extend for one week pre-event and two weeks following the conference.

    Further details at:


    Click on Meet SkyePharma to connect with latest events.


    Center of Excellence in Classic and Complex Oral Solid Forms


    Contact Skyepharma Production S.A.S.

    Simply fill out the form below to contact Skyepharma Production S.A.S. now.

    Send Skyepharma Production S.A.S. a Message